Literature DB >> 15184471

Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

Diane C McFadden1, Oscar Zaragoza, Arturo Casadevall.   

Abstract

The stability of cryptococcal antigen from Cryptococcus neoformans serotype A and D strains at different temperatures in serum and other solvents was studied. Samples stored at -20 or 4 degrees C had equivalent stabilities as measured by the Premier Cryptococcal Antigen kit and the Cryptococcal Antigen Latex Agglutination System (CALAS) kit. However, using the Premier Cryptococcal Antigen kit, there was a 91% loss of reactivity in samples incubated in human serum for 4 weeks at 37 degrees C. A loss of reactivity of more than 99% was observed after incubation at 45 degrees C for 4 weeks. The capsular antigen was not detected by the Premier Cryptococcal Antigen kit after 16 weeks at elevated temperatures. Antigen titers were also reduced in a latex agglutination assay (CALAS) after 4 weeks at 37 and 45 degrees C. The loss of antigen reactivity was a function of pH and temperature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184471      PMCID: PMC427815          DOI: 10.1128/JCM.42.6.2786-2788.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

2.  Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen.

Authors:  L D Gray; G D Roberts
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis.

Authors:  B P Currie; L F Freundlich; M A Soto; A Casadevall
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

4.  Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen.

Authors:  T C Wu; S Y Koo
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

5.  Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

Authors:  J R Hamilton; A Noble; D W Denning; D A Stevens
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.

Authors:  R Cherniak; H Valafar; L C Morris; F Valafar
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

7.  Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.

Authors:  Diane C McFadden; Arturo Casadevall
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

Review 9.  Cryptococcosis.

Authors:  John R Perfect; Arturo Casadevall
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

10.  Nonvalue of culturing cerebrospinal fluid for fungi.

Authors:  Joan Barenfanger; Jerry Lawhorn; Cheryl Drake
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more
  4 in total

1.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Authors:  Robert A Larsen; Peter G Pappas; John Perfect; Judith A Aberg; Arturo Casadevall; Gretchen A Cloud; Robert James; Scott Filler; William E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.

Authors:  Diane C McFadden; Bettina C Fries; Fang Wang; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2007-06-29

4.  Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformans.

Authors:  Oscar Zaragoza
Journal:  Front Microbiol       Date:  2011-09-06       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.